2020

1. A phase II, single-center, double-blind, randomized placebo-controlled trial to explore the efficacy and safety of intravenous melatonin in patients with COVID-19 admitted to the intensive care unit (MelCOVID study): A structured summary of a study protocol for a randomized controlled trial

   Trials, Vol. 21, Núm. 1

2. Clinical trial to test the efficacy of melatonin in COVID-19

   Journal of Pineal Research